{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T20:24:11Z","timestamp":1784751851583,"version":"3.55.0"},"reference-count":45,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2012,9,27]],"date-time":"2012-09-27T00:00:00Z","timestamp":1348704000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes Brain and Behavior"],"published-print":{"date-parts":[[2012,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Disulfiram is a cocaine pharmacotherapy that may act through increasing serotonin, benefiting patients with genetically low serotonin transporter levels (<jats:italic>5\u2010<jats:styled-content style=\"fixed-case\">HTTLPR<\/jats:styled-content><\/jats:italic>, S\u2032 allele carriers) and low serotonin synthesis (<jats:italic><jats:styled-content style=\"fixed-case\">TPH2<\/jats:styled-content><\/jats:italic>, A allele carriers). We stabilized 71 cocaine and opioid co\u2010dependent patients on methadone for 2\u2009weeks and randomized them into disulfiram and placebo groups for 10\u2009weeks. We genotyped the<jats:italic><jats:styled-content style=\"fixed-case\">SLC6A4<\/jats:styled-content>5\u2010<jats:styled-content style=\"fixed-case\">HTTLPR<\/jats:styled-content><\/jats:italic>(rs4795541, rs25531) and<jats:italic>T<jats:styled-content style=\"fixed-case\">PH2<\/jats:styled-content><\/jats:italic><jats:styled-content style=\"fixed-case\">1125A<\/jats:styled-content>&gt;T (rs4290270) variants and evaluated their role in moderating disulfiram treatment for cocaine dependence. Cocaine\u2010positive urines dropped from 78% to 54% for the disulfiram group and from 77% to 76% for the placebo group among the<jats:italic>5\u2010<jats:styled-content style=\"fixed-case\">HTTLPR<\/jats:styled-content><\/jats:italic>S\u2032 allele carriers (<jats:italic>F<\/jats:italic>\u2009=\u200916.2; df\u2009=\u20091,301;<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001).<jats:italic><jats:styled-content style=\"fixed-case\">TPH2<\/jats:styled-content><\/jats:italic>A allele carriers responded better to disulfiram than placebo (<jats:italic>F<\/jats:italic>\u2009=\u200916.0; df\u2009=\u20091,223;<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001). Patients with both an S\u2032 allele and a<jats:italic><jats:styled-content style=\"fixed-case\">TPH2<\/jats:styled-content><\/jats:italic>A allele reduced cocaine urines from 71% to 53% on disulfiram and had no change on placebo (<jats:italic>F<\/jats:italic>\u2009=\u200921.6; df\u2009=\u20091,185;<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.00001).<\/jats:bold><\/jats:p>","DOI":"10.1111\/j.1601-183x.2012.00839.x","type":"journal-article","created":{"date-parts":[[2012,8,23]],"date-time":"2012-08-23T17:59:21Z","timestamp":1345744761000},"page":"1001-1008","source":"Crossref","is-referenced-by-count":29,"title":["Modifying the role of serotonergic<i>5\u2010<scp>HTTLPR<\/scp><\/i>and<i><scp>TPH2<\/scp><\/i>variants on disulfiram treatment of cocaine addiction: a\u00a0preliminary study"],"prefix":"10.1111","volume":"11","author":[{"given":"D. A.","family":"Nielsen","sequence":"first","affiliation":[{"name":"Michael E. DeBakey V.A. Medical Center (MEDVAMC) Baylor College of Medicine Houston TX 77030 USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. J.","family":"Harding","sequence":"additional","affiliation":[{"name":"Michael E. DeBakey V.A. Medical Center (MEDVAMC) Baylor College of Medicine Houston TX 77030 USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. C.","family":"Hamon","sequence":"additional","affiliation":[{"name":"Laboratory of Statistical Genetics The Rockefeller University New York NY 10065 USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Huang","sequence":"additional","affiliation":[{"name":"Michael E. DeBakey V.A. Medical Center (MEDVAMC) Baylor College of Medicine Houston TX 77030 USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. R.","family":"Kosten","sequence":"additional","affiliation":[{"name":"Michael E. DeBakey V.A. Medical Center (MEDVAMC) Baylor College of Medicine Houston TX 77030 USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,9,27]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2003.09.032"},{"key":"e_1_2_5_3_1","first-page":"116","article-title":"Psychotherapeutic treatment of cocaine abuse: models for its evaluation alone and in combination with pharmacotherapy","volume":"135","author":"Carroll K.M.","year":"1993","journal-title":"NIDA Res Monogr"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1997.01830220041007"},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.1998.9357137.x"},{"key":"e_1_2_5_6_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.61.3.264"},{"key":"e_1_2_5_7_1","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0022-3565(25)26041-4","article-title":"The enzymatic oxidation of tryptophan to 5\u2010hydroxytryptophan in the biosynthesis of serotonin","volume":"132","author":"Cooper J.R.","year":"1961","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.c.30043"},{"key":"e_1_2_5_9_1","first-page":"576","article-title":"Differential effects of the 5\u2010HT(2A) receptor antagonist M100907 and the 5\u2010HT(2C) receptor antagonist SB242084 on cocaine\u2010induced locomotor activity, cocaine self\u2010administration and cocaine\u2010induced reinstatement of responding","volume":"27","author":"Fletcher P.J.","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(79)90383-7"},{"key":"e_1_2_5_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(80)90166-1"},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(99)00310-8"},{"key":"e_1_2_5_13_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2210-6-6"},{"key":"e_1_2_5_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ALC.0000150008.68473.62"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.1086\/503850"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-0998.2009.02591.x"},{"key":"e_1_2_5_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2009.12.010"},{"key":"e_1_2_5_18_1","doi-asserted-by":"crossref","unstructured":"Kosten T. Wu G. Huang W. Harding M.J. Hamon S.C. Lappalainen J.&Nielsen D.A.(2012) Pharmacogenetic randomized trial for cocaine abuse: disulfiram anddopamine \u03b2\u2010hydroxylase.Biol Psychiatry. doi:10.1016\/j.biopsych.2012.07.011.","DOI":"10.1016\/j.biopsych.2012.07.011"},{"key":"e_1_2_5_19_1","doi-asserted-by":"publisher","DOI":"10.1086\/501531"},{"key":"e_1_2_5_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/cne.902740211"},{"key":"e_1_2_5_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mp.4001923"},{"key":"e_1_2_5_22_1","unstructured":"Lima A.R. Lima M.S. Soares B.G.&Farrell M.(2002) Carbamazepine for cocaine dependence.Cochrane Database Syst Rev CD002023."},{"key":"e_1_2_5_23_1","doi-asserted-by":"crossref","unstructured":"Lima M.S. Reisser A.A. Soares B.G.&Farrell M.(2003) Antidepressants for cocaine dependence.Cochrane Database Syst Rev CD002950.","DOI":"10.1002\/14651858.CD002023"},{"key":"e_1_2_5_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1993.tb07435.x"},{"key":"e_1_2_5_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(93)90932-D"},{"key":"e_1_2_5_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2005.07.007"},{"key":"e_1_2_5_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/0740-5472(92)90062-S"},{"key":"e_1_2_5_28_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.284.13.1689"},{"key":"e_1_2_5_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/0197-0186(93)90065-D"},{"key":"e_1_2_5_30_1","doi-asserted-by":"publisher","DOI":"10.1037\/a0014592"},{"key":"e_1_2_5_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10519-007-9187-7"},{"key":"e_1_2_5_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00964915"},{"key":"e_1_2_5_33_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2000.9522198.x"},{"key":"e_1_2_5_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-294X.2004.02396.x"},{"key":"e_1_2_5_35_1","volume-title":"R: A Language and Environment for Statistical Computing","author":"R_Development_Core_Team","year":"2009"},{"key":"e_1_2_5_36_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2009.878"},{"key":"e_1_2_5_37_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0407-09.2009"},{"key":"e_1_2_5_38_1","unstructured":"SAMSHA(2011) Results from the 2010 National Survey on Drug Use and Health (NSDUH) series H\u201041 Rockville MD."},{"key":"e_1_2_5_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(78)90542-8"},{"key":"e_1_2_5_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mp.4001926"},{"key":"e_1_2_5_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-9338(97)83297-X"},{"key":"e_1_2_5_42_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-006-0349-8"},{"key":"e_1_2_5_43_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-008-0029-4"},{"key":"e_1_2_5_44_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.7071604"},{"key":"e_1_2_5_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneumeth.2004.09.020"},{"key":"e_1_2_5_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2005.05.004"}],"container-title":["Genes, Brain and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1601-183X.2012.00839.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1601-183X.2012.00839.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T04:38:55Z","timestamp":1744000735000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1601-183X.2012.00839.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,27]]},"references-count":45,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["10.1111\/j.1601-183X.2012.00839.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1601-183x.2012.00839.x","archive":["Portico"],"relation":{},"ISSN":["1601-1848","1601-183X"],"issn-type":[{"value":"1601-1848","type":"print"},{"value":"1601-183X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,27]]}}}